Key result
The 2015 AAGBI recommendations introduce significant updates to anaesthesia monitoring standards, including mandatory capnography for secured airways and a push towards quantitative NMB monitoring.
Answers are grounded in this paper and cite their sources.
The 2015 AAGBI recommendations introduce key updates to anaesthesia monitoring standards, including mandatory capnography and qualitative neuromuscular monitoring, aiming to improve patient safety.
The fifth edition of the Association of Anaesthetists of Great Britain and Ireland (AAGBI) standards of monitoring were published in Anaesthesia in January 2016 1, and a number of key new recommendations were included that have implications for all anaesthetists and departments in the UK and Ireland. It is important to remind ourselves that the aim of these recommendations was to reduce the incidence of adverse events and improve the safety of patients under the care of anaesthetists. The first edition was published in 1988 and was generally perceived to have had a profound, positive effect on clinical practice at that time. Each of the subsequent four updates and revisions can be considered as ‘marginal gains’ 2 based on more contemporary evidence and advances in technology. The lead author of this editorial (MC) chaired the Working Party of 13 experts who carefully considered every word, comma and full stop in the document, and we debated and agonised about the more contentious points. The consultation period generated many pertinent comments from AAGBI members, and the document was revised and rewritten many times. As a result, the recommendations were extended to include monitoring of patients during transfer within the hospital and also for procedures carried out under sedation under the care of an anaesthetist. Since publication, the fifth edition of standards for monitoring have been digested and debated in many anaesthetic departments, including my own. It is for each unit to decide how they influence local resource planning and clinical practice. For some, many or all of the standards are already being met, but for others, there may be a need to make changes to clinical practice and prioritise business cases to purchase new monitoring equipment. The two other authors, as editors of Anaesthesia (BJ and JP), have co-ordinated an international group of experts to provide updates on some key areas touched upon by the AAGBI guidelines. The purpose of this article was to highlight what we see as the main updates (including those that are contentious) and introduce a supplement that includes both experimental and educational material. One significant update is for monitoring of neuromuscular blocking drugs to become mandatory, with quantitative monitoring being recommended as the ideal to which to aspire. This is no longer really contentious, especially after the clear recommendation from NAP5 3, 4. However, debates centred around quantitative vs. qualitative monitoring. The Working Party felt strongly that the minimum standard is to use qualitative neuromuscular monitoring (a ‘regular’ nerve stimulator), and that these devices should be used from induction to recovery. We know that there is great variation in both onset and offset of neuromuscular blocking drugs (NMB), and clinical assessment alone is inadequate. Residual block is detectable in over a third of patients 120 min after a single dose of neuromuscular blocking agent, and NAP5 reported on the morbidity that results from inadequate reversal in the recovery room 5, 6. A survey published in 2010 7 found that < 20% of UK anaesthetists were routinely monitoring neuromuscular blockade. This also seemed to be the case from the NAP5 activity survey 8, so there is great scope to improve this. The working party debated whether or not to make quantitative NMB monitors (that measure train of four ratio) the minimum standard in line with evidence of their superiority. However, in view of the current low penetration of any routine NMB monitoring, we decided to limit the recommendation to encouraging departments to ‘move towards’ quantitative monitoring when purchasing new monitors. We believe that quantitative monitors will become the minimal standard in the next edition of the standards. The extra cost of these devices is one barrier to their more rapid and enthusiastic take up in the UK and Ireland. The other barrier is the need for training for anaesthetists on using quantitative NMB monitors. My own department has successfully raised awareness and knowledge on NMB monitoring by running a programme of ‘tea trolley’ training sessions for all our personnel. The article by Naguib et al. in this supplement provides excellent detail on these monitors 9. One potentially contentious new recommendation is that capnography monitoring is also now mandatory in any patient, whose airway is secured with a tracheal tube or supraglottic airway device (SAD), or is deeply sedated without an artificial airway device in situ. The rationale for this was simple. Capnography is not only a means to know the tracheal tube is correctly sited; it is also a means to confirm satisfactory ventilation or a clear airway conduit. So the relevant principle is that it is necessary in a compromised patient (i.e. one who is anaesthetised or deeply sedated), regardless of where that patient is. In other words, there is no substantive difference between a patient in theatre, in the recovery area or in transit between the two, if the condition of the patient is the same (i.e. unconscious) at each of these sites. Nevertheless, this recommendation will almost certainly require considerable change in practice and investment in additional monitoring. In summary, a capnograph needs to be available at each recovery room's bed space to monitor patients who have tracheal tubes or supraglottic airways in situ, or who are yet fully to emerge from the effects of anaesthesia. Currently, this standard is not met in just over 50% of hospitals in 2013 10, although the NAP4 report appeared to have influenced a rise 11. This will require purchase of new hardware for some hospitals: at least one department to our knowledge has recently used the AAGBI recommendations to submit a successful business case to achieve this. This is gratifying, and an example of how AAGBI recommendations can help to improve standards and safety. In line with this capnography recommendation, all minimal monitoring should be continued during transfer from the operating theatre to the recovery room. Anaesthetists may be accustomed to escorting patients from theatre to the recovery room with little or no monitoring, using clinical observation alone. The duration of these transfers vary between hospitals depending on the geography of the operating suite, but can range from a few seconds to a few minutes. This can be a time of significant change in a patient's vital signs, so the ability to provide uninterrupted monitoring from induction to full recovery is now the goal. The period of time without monitoring should be kept to an absolute minimum (ideally, less than a minute), particularly if the patient is not maintaining their own airway. Transfers taking significant time must be monitored. Many units already have monitoring systems that move with the patient from anaesthetic room to theatre and then into recovery, but those that do not should seek solutions for the future. This will require capital investment for some departments, but the recommendation should also drive manufacturers to make such principles a standard. The AAGBI recommendations now state that depth of anaesthesia (DoA) monitoring is considered necessary when using total intravenous anaesthetic (TIVA) techniques with NMB. This is another feature that arises directly from the recommendations of NAP5. One potentially contentious point is that the advice does not extend to patients undergoing volatile-based anaesthesia, with (or without) neuromuscular blockade. In that regard, the AAGBI advice does not seem consistent with, for example, NICE guidance on the use of EEG-based monitoring 12. Again, this point was extensively debated, but our committee felt that, whereas there was complete consensus in relation to TIVA with NMB, there was a continued debate in relation to volatile agents, where some authorities argue that end-tidal monitoring is equally effective 13 and by implication, that EEG-based monitoring could be misleading. Moreover, the NICE guidelines themselves have been criticised for shortcomings 14, with even non-UK authors describing them as ‘an example of premature implementation…that is lacking evidential backing’ 15. Such differences in opinion made it impossible to mandate use in conditions other than TIVA with NMB. Of course, the use of EEG-based monitors in non-paralysed patients seems unlikely to be preventative, since the incidence of awareness is so low and even methods like the isolated forearm technique do not reveal any underlying awareness 16, 17. The AAGBI recommendations leave anaesthetists free to use these monitors in any situation they wish, but stipulate under which conditions they should be regarded as strongly recommended, if not essential. In this Supplement, Hajat et al. discuss several issues pertaining to these monitors 18. In relation to tracheal or SAD cuff pressures, what might be regarded a minor recommendation is nonetheless a potentially controversial one. There can be morbidity resulting from excessively high pressures in tracheal tubes or cuffed supraglottic airways 19. It has not been routine practice to measure and limit cuff pressures up until now, but the AAGBI guidelines have now recommended that cuff manometers should be used. A recent audit at the hospital of the lead author (MC) found that in > 40% of tracheal tubes and > 60% of supraglottic airways, cuff pressures were inflated above the manufacturer's recommended maxima, with ~30% inflated significantly above that level. Cuff pressure manometers are relatively inexpensive, so it would not require huge investment to introduce this simple improvement in practice 20. As stated earlier, the anaesthetist must remain present throughout general anaesthesia or regional blocks with sedation (the anaesthetist is the ‘primary monitor’). In this issue, Larsson provides insight into how to monitor this ‘primary monitor’ 21. This wording now extends to ‘…or suitably qualified Physician Assistant (Anaesthesia)’. The AAGBI Working Party carefully considered and concurred with the consensus statement from Regional Anaesthesia UK 5, that in certain specific situations such as procedures on the limb, healthy patients may be supervised by a suitably qualified healthcare worker other than an anaesthetist. In this issue of the Supplement, Ode et al. discuss other aspects of the monitoring of regional blockade 22. Attention was also devoted to organisational elements in monitoring (see Rutherford's article in this Supplement for further discussion of how to monitor the team 23). An aspirational recommendation was included to encourage anaesthetic departments to allow anaesthetists working alone during long procedures to be relieved for meal and comfort breaks. This may not be current custom and practice, but the Working Party felt that, if indeed anaesthetists were ‘the primary monitor’ then it was important for them to remain fresh. Both for the wellbeing of anaesthetist and also to reduce the risk of errors (due to fatigue, hunger or the need to visit the toilet), some relief was essential. Even more importantly, it is recommended that departments ensure there is always a spare anaesthetist within a theatre suite. This is not only for the purposes of reliefs and breaks, but also to provide assistance when it is needed. Otherwise, single-handed anaesthetists face the dilemma of depriving their own patient of their ‘primary monitor’ if they leave to assist a colleague. The manpower implications of this will challenge some departments with very limited resources, but it is hoped that the recommendation will help to support the important case for change. Adoption of electronic anaesthetic record systems are encouraged to improve the quality and accuracy of data recording during anaesthesia and several eminent AAGBI members who responded during the consultation period expressed disappointment that this recommendation (carried over from the Fourth Edition) was not strengthened. Fiscal pressures in the NHS have undoubtedly played a part in the low adoption rate in the UK and Ireland compared with other developed countries. There is a need for affordable, high quality e-anaesthesia record systems that integrate with primary and secondary care electronic medical record systems to be developed and available for NHS hospitals. It will be interesting to see how things have moved on in this area when the Sixth Edition is published. Other articles in this issue focus on specific areas of cardiovascular and respiratory monitoring 24-26, and include outlines of the most recent research – something that is essential as monitoring develops. In summary, while aspects of the Fifth Edition of the AAGBI standards of monitoring may be regarded as ‘marginal gains’ on current practice, this article makes clear that many of the new recommendations are radical enough to challenge the anaesthetic community in its practice, research endeavours and resource support for many years to come. MC Chaired and JP was a member of the AAGBI Working Party on monitoring referred to in this article. JP and BJ are editors of Anaesthesia.
No takes yet. Share an insight, caveat, or question.
Checketts et al. (2017) conducted an editorial in Anaesthesia monitoring. 2015 AAGBI recommendations for standards of monitoring was evaluated. The 2015 AAGBI recommendations introduce significant updates to anaesthesia monitoring standards, including mandatory capnography for secured airways and a push towards quantitative NMB monitoring.
Synapse has enriched 10 related papers. Consider them for comparative context: